
Remodeling T cell compartments during anti-CD3 immunotherapy of type 1 diabetes
Keywords: Type 1 diabetes; Immunotherapy; Anti-CD3 monoclonal antibody; T lymphocyte; Immune tolerance; T cell inactivation;